Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22658895 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
Conditions: Leukemia;   Lymphoma
Interventions: Drug: Insulin Glargine;   Drug: Insulin Aspart

Indicates status has not been verified in more than two years